| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/05/2001 | WO2001022993A2 MUCOSAL DTPa VACCINES |
| 04/05/2001 | WO2001022992A2 Influenza vaccine |
| 04/05/2001 | WO2001022990A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 04/05/2001 | WO2001022973A1 The use of a positively charged carbohydrate polymer for the prevention of infection |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022967A1 Compositions having improved stability |
| 04/05/2001 | WO2001022950A2 Diosolane nucleoside analogs for the treatment or prevention of viral infection |
| 04/05/2001 | WO2001022938A1 Antiviral compositions |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001022916A2 Novel hev antigenic peptide and methods |
| 04/05/2001 | WO2001008657A3 Personal care articles |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000073284A3 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
| 04/05/2001 | WO2000072820A3 Injectable anesthetic formulation |
| 04/05/2001 | WO2000069455A3 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 04/05/2001 | WO2000068198A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 04/05/2001 | WO2000066580A3 Antifungal ethers |
| 04/05/2001 | WO2000066126A3 Liposome compositions for improved drug retention |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000056736A3 Use of non-nucleoside reverse transcriptase inhibitor (mni) for the treatment of hiv infection |
| 04/05/2001 | WO2000051547A3 Inhibitors of prenyl-protein transferase |
| 04/05/2001 | WO2000050064A3 Synergistic combination for treatment of viral-mediated diseases |
| 04/05/2001 | WO2000045803A3 Use of 5-aminosalicylates as antimicrobial agents |
| 04/05/2001 | WO2000040228A3 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 04/05/2001 | WO2000015036A9 Topical dermal antimicrobial compositions |
| 04/05/2001 | WO2000002522A9 Anthrax vaccine |
| 04/05/2001 | WO1996018391B1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 04/05/2001 | US20010000143 Using dimethyl ether and elevated temperature/pressure to dissolve the solid; releasing the pressure to precipitate the fine powder and expand the ether into a gas; drugs; vitamins; carotenoid, especially beta-carotene; foods; cosmetics |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | CA2811455A1 Highly conserved genes and their use to generate species-specific, genus-specific, family-specific, group-specific and universal nucleic acid probes and amplification primers to rapidly detect and identify algal, archaeal, bacterial, fungal and parasitical microorganisms from clinical specimens for diagnosis |
| 04/05/2001 | CA2616210A1 Influenza vaccine compositions |
| 04/05/2001 | CA2388461A1 Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2388005A1 Low dose ifn-gamma for treatment of disease |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386077A1 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | CA2386032A1 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 04/05/2001 | CA2386025A1 Vaccine against neisseria infection |
| 04/05/2001 | CA2386014A1 Influenza vaccine |
| 04/05/2001 | CA2385990A1 Compositions having improved stability |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385884A1 26 human secreted proteins |
| 04/05/2001 | CA2385349A1 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384723A1 Vaccine |
| 04/05/2001 | CA2384662A1 41 human secreted proteins |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/05/2001 | CA2384584A1 38 human secreted proteins |
| 04/05/2001 | CA2384382A1 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/05/2001 | CA2384265A1 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | CA2379623A1 Immunologically significant herpes simplex virus antigens |
| 04/04/2001 | EP1088890A2 Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same |
| 04/04/2001 | EP1088830A2 Hepatitis b surface antigen particles |
| 04/04/2001 | EP1088828A2 Synthesis of carbamate ketolide antibiotics |
| 04/04/2001 | EP1088826A1 Process for the preparation of potassium clavulanate |
| 04/04/2001 | EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/04/2001 | EP1088100A2 Proteasomal activity |
| 04/04/2001 | EP1088098A2 Fitness assay and associated methods |
| 04/04/2001 | EP1088077A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 04/04/2001 | EP1088075A2 Aav scleroprotein, production and use thereof |
| 04/04/2001 | EP1088070A2 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087987A1 A compound, wf002, production thereof and use thereof |
| 04/04/2001 | EP1087984A2 acpS |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087792A1 NrdD |
| 04/04/2001 | EP1087787A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 04/04/2001 | EP1087783A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF $i(HELICOBACTER PYLORI)-ASSOCIATED DISORDERS |
| 04/04/2001 | EP1087778A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 04/04/2001 | EP1087768A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action |
| 04/04/2001 | EP1087661A1 Il-8 receptor antagonists |
| 04/04/2001 | EP0808315B1 Carbapenem-3-carboxylic acid ester derivatives |
| 04/04/2001 | EP0588796B1 Sampangine derivatives useful as antifungal and antimycobacterial agents |
| 04/04/2001 | CN1290270A Streptogramin derivatives prepartion method and compositions containing same |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290255A Dihydroxyhexanoic acid derivatives |
| 04/04/2001 | CN1290253A Heterocyclic topoisomerase poisons |
| 04/04/2001 | CN1290180A Sterile complex of therapeutic peptide bond to polysaccharide |
| 04/04/2001 | CN1290177A Crystallographically stable amorphous sephalosporin compositions and process for producing the same |
| 04/04/2001 | CN1290175A Live vaccine for human immunodeficiency virus |
| 04/04/2001 | CN1290174A Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/04/2001 | CN1290173A Over-expressing homologous antigen vaccine and method of making same |
| 04/04/2001 | CN1290168A Inhibition of membrane-associated viral replication |
| 04/04/2001 | CN1289778A Synthesis of ketonic acid lactone amino carbomate antibiotics |
| 04/04/2001 | CN1289766A Penicillene compounds and derivatives therefrom |
| 04/04/2001 | CN1289597A Medicine for treating fungus diseases |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/04/2001 | CN1063965C Compounded Chinese medicinal preparation for diseases of infants and preparing method thereof |
| 04/03/2001 | US6211386 Hydrogenating precursor compound, the e-geometrical isomer thereof or a mixture of the z- and e-isomers in the presence of catalyst containing rh, a chiral ligand with at least one phosphorous atom |
| 04/03/2001 | US6211376 8-hydroxy-7-substituted quinolines as anti-viral agents |
| 04/03/2001 | US6211367 Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity |
| 04/03/2001 | US6211349 Protonated/acidified nucleic acids and methods of use |
| 04/03/2001 | US6211348 As antibiotics |